M
Michel Journet
Researcher at Merck & Co.
Publications - 85
Citations - 1599
Michel Journet is an academic researcher from Merck & Co.. The author has contributed to research in topics: Radical cyclization & Propargyl. The author has an hindex of 23, co-authored 85 publications receiving 1497 citations. Previous affiliations of Michel Journet include University of Rochester & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Functional analysis of the Pseudomonas aeruginosa autoinducer PAI.
Luciano Passador,Kenneth D. Tucker,K R Guertin,Michel Journet,Andrew S. Kende,Barbara H. Iglewski +5 more
TL;DR: A series of structural analogs of the Pseudomonas aeruginosa autoinducer obtained and tested for their ability to act as autoinducers in stimulating the expression of the gene for elastase by measuring beta-galactosidase production from a lasB-lacZ gene fusion in the presence of the transcriptional activator LasR suggest that the length of the acyl side chain of theautoinducer molecule is the most critical factor for activity.
Journal ArticleDOI
A practical synthesis of a COX-2-specific inhibitor.
Ian W. Davies,Jean-François Marcoux,Edward G. Corley,Michel Journet,Dongwei Cai,Michael Palucki,Jimmy Ming-Tai Wu,Robert D. Larsen,Kai Rossen,Philip J. Pye,Lisa DiMichele,Peter G. Dormer,Paul J. Reider +12 more
TL;DR: A number of synthetic strategies to the Cox-2 specific inhibitor 1 have been described, leading to the identification of a novel pyridine construction using annulation of ketone 2 using a vinamidinium species 29 and ammonia in 97% assay yield.
Journal ArticleDOI
Highly efficient synthesis of α,β-acetylenic aldehydes from terminal alkynes using DMF as the formylating reagent
TL;DR: In this paper, the formylation of lithium acetylides with DMF led to α,β-acetylenic aldehydes in excellent yields (>94%) using a reverse quench into a phosphate buffer (10% aqueous KH 2 PO 4,4 equiv).
Journal ArticleDOI
Asymmetric synthesis of telcagepant, a CGRP receptor antagonist for the treatment of migraine.
Feng Xu,Michael J. Zacuto,Naoki Yoshikawa,Richard Desmond,Scott Hoerrner,Tetsuji Itoh,Michel Journet,Guy R. Humphrey,Cameron J. Cowden,Neil A. Strotman,Paul N. Devine +10 more
TL;DR: A highly efficient, asymmetric synthesis of telcagepant, a CGRP receptor antagonist for the treatment of migraine, is described, which features the first application of iminium organocatalysis on an industrial scale.
Journal ArticleDOI
Radical cyclization of (bromomethyl)dimethylsilyl propargyl ethers. Regio-, chemo-, and stereoselectivity
Michel Journet,Max Malacria +1 more
TL;DR: In this article, the α-cyclopropyl radical which is involved in the Stork-Beckwith mechanism of the 5-versus-6-membered ring formation in the vinyl radical cyclization was intercepted.